Min Xu

1.9k total citations
94 papers, 1.4k citations indexed

About

Min Xu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Min Xu has authored 94 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Cardiology and Cardiovascular Medicine and 15 papers in Cancer Research. Recurrent topics in Min Xu's work include Cardiovascular Function and Risk Factors (14 papers), Atrial Fibrillation Management and Outcomes (9 papers) and MicroRNA in disease regulation (7 papers). Min Xu is often cited by papers focused on Cardiovascular Function and Risk Factors (14 papers), Atrial Fibrillation Management and Outcomes (9 papers) and MicroRNA in disease regulation (7 papers). Min Xu collaborates with scholars based in China, United States and Belgium. Min Xu's co-authors include Glenn L. Wilson, Albert W. Pearsall, Valentina Grishko, Don B. Arnold, Thomas J. Wandless, Xiaoli Huang, Lichan Tao, Lei Yang, Liangxing Wang and Ling Yang and has published in prestigious journals such as Blood, Development and Cancer Research.

In The Last Decade

Min Xu

85 papers receiving 1.4k citations

Peers

Min Xu
Ian C. Harding United States
Wei Meng China
Qing Lu United States
Jun Ni China
Yi Xu China
Hui Shen China
Hao Zhao China
Ian C. Harding United States
Min Xu
Citations per year, relative to Min Xu Min Xu (= 1×) peers Ian C. Harding

Countries citing papers authored by Min Xu

Since Specialization
Citations

This map shows the geographic impact of Min Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Xu more than expected).

Fields of papers citing papers by Min Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Xu. The network helps show where Min Xu may publish in the future.

Co-authorship network of co-authors of Min Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Min Xu. A scholar is included among the top collaborators of Min Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Xu. Min Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Xu, Min, et al.. (2025). The impact of SGLT2 inhibitors on cardiac remodeling after myocardial infarction: an updated meta-analysis of randomized controlled trials. Frontiers in Pharmacology. 16. 1699066–1699066. 1 indexed citations
4.
Cai, Jia, Min Xu, Shun‐Peng Zhu, et al.. (2025). Multi-target therapeutics of geraniin from Geranium wilfordii Maxim. and related species: Mechanisms and applications. Journal of Ethnopharmacology. 356. 120765–120765.
7.
Tan, Jinfeng, Yujing Xiong, Xiaohui Wang, et al.. (2024). Influencing factors for postpartum depression in women with gestational diabetes mellitus. Frontiers in Endocrinology. 15. 1423127–1423127. 4 indexed citations
9.
Chen, Yuchen, et al.. (2023). A Novel Drug Delivery System: Hyodeoxycholic Acid-Modified Metformin Liposomes for Type 2 Diabetes Treatment. Molecules. 28(6). 2471–2471. 11 indexed citations
10.
Tao, Lichan, Zihan Qin, Lin Lin, et al.. (2023). Long noncoding RNA lncPostn links TGF-β and p53 signaling pathways to transcriptional regulation of cardiac fibrosis. American Journal of Physiology-Cell Physiology. 326(2). C457–C472. 2 indexed citations
11.
Liu, Xia, et al.. (2023). Evaluation of the electrocardiogram RV5/V6 criteria in the diagnosis of left ventricular hypertrophy in marathon runners. Journal of Clinical Hypertension. 25(7). 638–646. 2 indexed citations
12.
13.
Zhang, Shengjie, et al.. (2023). Spatial differences in the marine industry based on marine-related enterprises: A case study of Jiangsu Province, China. Regional Studies in Marine Science. 62. 102954–102954. 10 indexed citations
14.
Sun, Yuzhe, et al.. (2022). Potential links between COVID-19 and periodontitis: a bioinformatic analysis based on GEO datasets. BMC Oral Health. 22(1). 520–520. 6 indexed citations
15.
Zhou, Xiaofei, Xi Tan, Xincheng Huang, et al.. (2022). The Status of Oxidative Stress in Patients with Alcohol Dependence: A Meta-Analysis. Antioxidants. 11(10). 1919–1919. 19 indexed citations
17.
Zeng, Lian, Zhen Zhang, Min Xu, et al.. (2021). P53 inhibitor pifithrin‐α inhibits ropivacaine‐induced neuronal apoptosis via the mitochondrial apoptosis pathway. Journal of Biochemical and Molecular Toxicology. 35(8). e22822–e22822. 7 indexed citations
18.
Xu, Min, et al.. (2020). Modified Cornell electrocardiographic criteria in the assessment of left ventricular hypertrophy geometry of patients with essential hypertension. Journal of Clinical Hypertension. 22(7). 1239–1246. 6 indexed citations
19.
Li, Xiaoli, You Zhou, Min Xu, et al.. (2020). Data mining on varieties, therapeutic uses and medicinal characteristics of Traditional Chinese Medicine preparations for treating hair loss. Tropical Journal of Pharmaceutical Research. 19(11). 2461–2475. 1 indexed citations
20.
Hou, Yanan, Jia Xu, Wen Zhu, et al.. (2019). Association between mid-upper arm circumference and cardiometabolic risk in Chinese population: a cross-sectional study. BMJ Open. 9(9). e028904–e028904. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026